372 related articles for article (PubMed ID: 16611086)
1. Ruthenium complexes as anticancer agents.
Kostova I
Curr Med Chem; 2006; 13(9):1085-107. PubMed ID: 16611086
[TBL] [Abstract][Full Text] [Related]
2. DNA binding mode of ruthenium complexes and relationship to tumor cell toxicity.
Brabec V; Nováková O
Drug Resist Updat; 2006 Jun; 9(3):111-22. PubMed ID: 16790363
[TBL] [Abstract][Full Text] [Related]
3. Multinuclear Organometallic Ruthenium-Arene Complexes for Cancer Therapy.
Babak MV; Ang WH
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394025
[TBL] [Abstract][Full Text] [Related]
4. Metal complexes with aromatic N-containing ligands as potential agents in cancer treatment.
Zhao G; Lin H
Curr Med Chem Anticancer Agents; 2005 Mar; 5(2):137-47. PubMed ID: 15777221
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium anticancer compounds: myths and realities of the emerging metal-based drugs.
Bergamo A; Sava G
Dalton Trans; 2011 Aug; 40(31):7817-23. PubMed ID: 21629963
[TBL] [Abstract][Full Text] [Related]
6. Rhodium and its compounds as potential agents in cancer treatment.
Katsaros N; Anagnostopoulou A
Crit Rev Oncol Hematol; 2002 Jun; 42(3):297-308. PubMed ID: 12050021
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo activity and cross resistance profiles of novel ruthenium (II) organometallic arene complexes in human ovarian cancer.
Aird RE; Cummings J; Ritchie AA; Muir M; Morris RE; Chen H; Sadler PJ; Jodrell DI
Br J Cancer; 2002 May; 86(10):1652-7. PubMed ID: 12085218
[TBL] [Abstract][Full Text] [Related]
8. Ruthenium-based chemotherapeutics: are they ready for prime time?
Antonarakis ES; Emadi A
Cancer Chemother Pharmacol; 2010 May; 66(1):1-9. PubMed ID: 20213076
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
Abid M; Shamsi F; Azam A
Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
[TBL] [Abstract][Full Text] [Related]
10. New platinum and ruthenium complexes--the latest class of potential chemotherapeutic drugs--a review of recent developments in the field.
Amin A; Buratovich MA
Mini Rev Med Chem; 2009 Nov; 9(13):1489-503. PubMed ID: 20205631
[TBL] [Abstract][Full Text] [Related]
11. Anticancer activity of two novel ruthenium compounds in gastric cancer cells.
Ramírez-Rivera S; Pizarro S; Gallardo M; Gajardo F; Delgadillo A; De La Fuente-Ortega E; MacDonnell FM; Bernal G
Life Sci; 2018 Nov; 213():57-65. PubMed ID: 30326218
[TBL] [Abstract][Full Text] [Related]
12. Non platinum metal complexes as anti-cancer drugs.
Ott I; Gust R
Arch Pharm (Weinheim); 2007 Mar; 340(3):117-26. PubMed ID: 17315259
[TBL] [Abstract][Full Text] [Related]
13. Next-generation anticancer metallodrugs.
Komeda S; Casini A
Curr Top Med Chem; 2012; 12(3):219-35. PubMed ID: 22236158
[TBL] [Abstract][Full Text] [Related]
14. Neutron activation increases activity of ruthenium-based complexes and induces cell death in glioma cells independent of p53 tumor suppressor gene.
Montel AM; Dos Santos RG; da Costa PR; Silveira-Lacerda EP; Batista AA; Dos Santos WG
Biometals; 2017 Apr; 30(2):295-305. PubMed ID: 28258507
[TBL] [Abstract][Full Text] [Related]
15. Beyond platinums: gold complexes as anticancer agents.
Nardon C; Boscutti G; Fregona D
Anticancer Res; 2014 Jan; 34(1):487-92. PubMed ID: 24403506
[TBL] [Abstract][Full Text] [Related]
16. Approaching tumour therapy beyond platinum drugs: status of the art and perspectives of ruthenium drug candidates.
Bergamo A; Gaiddon C; Schellens JH; Beijnen JH; Sava G
J Inorg Biochem; 2012 Jan; 106(1):90-9. PubMed ID: 22112845
[TBL] [Abstract][Full Text] [Related]
17. Medicinal organometallic chemistry: designing metal arene complexes as anticancer agents.
Peacock AF; Sadler PJ
Chem Asian J; 2008 Nov; 3(11):1890-9. PubMed ID: 18712745
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, characterization and biological evaluation of novel Ru(II)-arene complexes containing intercalating ligands.
Nikolić S; Rangasamy L; Gligorijević N; Aranđelović S; Radulović S; Gasser G; Grgurić-Šipka S
J Inorg Biochem; 2016 Jul; 160():156-65. PubMed ID: 26818702
[TBL] [Abstract][Full Text] [Related]
19. Is matching ruthenium with dithiocarbamato ligands a potent chemotherapeutic weapon in oncology?
Nardon C; Brustolin L; Fregona D
Future Med Chem; 2016; 8(2):211-26. PubMed ID: 26807601
[TBL] [Abstract][Full Text] [Related]
20. Design of Ru-arene Complexes for Antitumor Drugs.
Su W; Li Y; Li P
Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]